Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Busyzzindahouseon Dec 02, 2016 6:35pm

151 Views

Post# 25549275

How some change their tone as soon as we ascend

Unreal how some bashers are now all happy and invested and voicing their positive feedback abt how gr8 NF is.......... How do u guys even go to sleep knowing that you misguide new investors ....... the way some bashed here for the last 4 days ....... unreal ......... sad state of affairs and quite disturbing how these idiots go to bashing the company and fundamentals 1 minute and loving it the next.......

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario